Perfromance Wealth Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Perfromance Wealth Partners's DXCM Position: Q2 2026 in Review
Perfromance Wealth Partners increased its DexCom (DXCM) stake by 12% in Q2 2026, buying an estimated $182K and bringing the position to 25,838 shares worth $1.74M. The position accounts for 0.04% of the portfolio, ranked #70.
Perfromance Wealth Partners first reported a position in DXCM in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.21M in Q2 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Perfromance Wealth Partners held 25,838 shares of DexCom worth $1.74M as of Q2 2026.
- Perfromance Wealth Partners bought 2,734 DexCom shares in Q2 2026, an estimated $182K.
- DexCom made up 0.04% of Perfromance Wealth Partners's portfolio in Q2 2026, its #70 holding.
- Perfromance Wealth Partners first reported a position in DexCom in Q4 2021 and has held it in 19 quarters since.
- Perfromance Wealth Partners's DexCom position peaked at $5.21M in Q2 2023.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Perfromance Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.